APLS vs. SPY
Compare and contrast key facts about Apellis Pharmaceuticals, Inc. (APLS) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: APLS or SPY.
Correlation
The correlation between APLS and SPY is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
APLS vs. SPY - Performance Comparison
Key characteristics
APLS:
-1.07
SPY:
1.91
APLS:
-1.70
SPY:
2.57
APLS:
0.79
SPY:
1.35
APLS:
-0.81
SPY:
2.88
APLS:
-1.22
SPY:
11.96
APLS:
47.56%
SPY:
2.03%
APLS:
54.32%
SPY:
12.68%
APLS:
-74.65%
SPY:
-55.19%
APLS:
-69.80%
SPY:
0.00%
Returns By Period
In the year-to-date period, APLS achieves a -11.69% return, which is significantly lower than SPY's 4.34% return.
APLS
-11.69%
-5.86%
-27.65%
-59.03%
-6.29%
N/A
SPY
4.34%
2.33%
10.15%
23.99%
14.44%
13.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
APLS vs. SPY — Risk-Adjusted Performance Rank
APLS
SPY
APLS vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Apellis Pharmaceuticals, Inc. (APLS) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
APLS vs. SPY - Dividend Comparison
APLS has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
APLS Apellis Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.16% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
APLS vs. SPY - Drawdown Comparison
The maximum APLS drawdown since its inception was -74.65%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for APLS and SPY. For additional features, visit the drawdowns tool.
Volatility
APLS vs. SPY - Volatility Comparison
Apellis Pharmaceuticals, Inc. (APLS) has a higher volatility of 10.85% compared to SPDR S&P 500 ETF (SPY) at 3.13%. This indicates that APLS's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.